Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;59(12):3053-61.
doi: 10.1007/s10620-014-3272-6. Epub 2014 Jul 17.

Comparative effectiveness research of chronic hepatitis B and C cohort study (CHeCS): improving data collection and cohort identification

Affiliations

Comparative effectiveness research of chronic hepatitis B and C cohort study (CHeCS): improving data collection and cohort identification

Mei Lu et al. Dig Dis Sci. 2014 Dec.

Abstract

Background and aims: The Chronic Hepatitis Cohort Study (CHeCS) is a longitudinal observational study of risks and benefits of treatments and care in patients with chronic hepatitis B (HBV) and C (HCV) infection from four US health systems. We hypothesized that comparative effectiveness methods-including a centralized data management system and an adaptive approach for cohort selection-would improve cohort selection while controlling data quality and reducing the cost.

Methods: Cohort selection and data collection were performed primarily via the electronic health record (EHR); cases were confirmed via chart abstraction. Two parallel sources fed data to a centralized data management system: direct EHR data collection with common data elements, and chart abstraction via electronic data capture. An adaptive Classification and Regression Tree (CART) identified a set of electronic variables to improve case ascertainment accuracy.

Results: Over 16 million patient records were collected on 23 case report forms in 2006-2008. The vast majority of data (99.2%) were collected electronically from EHR; only 0.8% was collected via chart abstraction. Initial electronic criteria identified 12,144 chronic hepatitis patients; 10,098 were confirmed via chart abstraction with positive predictive values (PPV) 79 and 83% for HBV and HCV, respectively. CART-optimized models significantly increased PPV to 88 for HBV and 95% for HCV.

Conclusions: CHeCS is a comparative effectiveness research project that leverages electronic centralized data collection and adaptive cohort identification approaches to enhance study efficiency. The adaptive CART model significantly improved the positive predictive value of cohort identification methods.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest Stuart C. Gordon receives grant/research support from AbbVie Pharmaceuticals, Bristol-Myers Squibb, Gilead Pharmaceuticals, GlaxoSmithKline, Intercept Pharmaceuticals, Merck, and Vertex Pharmaceuticals. He is also a consultant/advisor for Amgen, Bristol-Myers Squibb, CVS Caremark, Gilead Pharmaceuticals, Merck, Novartis, and Vertex Pharmaceuticals and is on the Data Monitoring Board for Tibotec/Janssen Pharmaceuticals. The other authors have no potential conflicts of interest.

Figures

Fig. 1
Fig. 1
The HMORN VDW data structures [11]
Fig. 2
Fig. 2
CART HBV model
Fig. 3
Fig. 3
CART HCV model

References

    1. Dreyer NA, Schneeweiss S, McNeil BJ, et al. GRACE principles: recognizing high-quality observational studies of comparative effectiveness. Am J Manag Care. 2010;16:467–471. - PubMed
    1. Alford L, AppSc B. On differences between explanatory and pragmatic clinical trials. N Z J Physiother. 2006;35:12–16.
    1. Tunis SR, Benner J, McClellan M. Comparative effectiveness research: policy context, methods development and research infrastructure. Stat Med. 2010;29:1963–1976. - PubMed
    1. Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining inference and prediction. New York: Springer; 2009.
    1. Johnson ML, Chitnis AS. Comparative effectiveness research: guidelines for good practices are just the beginning. Expert Rev Pharmacoecon Outcomes Res. 2011;11:51–57. - PubMed

Publication types

Substances

LinkOut - more resources